Diabetes Drug Avandia Gets No Sugar from Regulators
GlaxoSmithKline’s Avandia diabetes drug got hit with a double whammy from regulators on both sides of the pond Thursday. The European Medicines Agency announced plans to yank the drug from the market in the coming months, while…